Internal Medicine · Vero Beach, FL
NPI
1356387435
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3715 7th Terrace
Vero Beach, FL, 32960
Phone (772) 770-2664
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
699 services
Medicare patients, 2024
145
Average age 79
Drug cost, 2024
$3.3M
5,609 prescriptions
Company payments, 2025
$1,174
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald Pierone Jr. was code 99213 (office e&m - established), 287 times for 111 patients. In total Gerald Pierone Jr. billed 699 services in 32 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 287 | 111 | $63.43 | $18K |
| 90662 Vaccine Product | Office | 46 | 44 | $81.61 | $3,754 |
| G0008 Administration of influenza virus vaccine | Office | 45 | 43 | $32.91 | $1,481 |
| 99212 Office E&M - Established | Office | 28 | 23 | $38.83 | $1,087 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 17 | 12 | $61.84 | $1,051 |
By year: 2022 $41K for 1,093 services; 2023 $31K for 1,431 services; 2024 $28K for 699 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 17 | 12 | $61.84 | $1,051 |
Medicare prescription drug claims, 2024
In 2024, the drug Gerald Pierone Jr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 249 prescriptions and refills. In total Gerald Pierone Jr. wrote 5,609 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 249 | 484 | 48 | $1,910 |
| Amlodipine Besylate Generic | 236 | 434 | 42 | $1,173 |
| Levothyroxine Sodium Generic | 120 | 275 | 29 | $1,157 |
| Tivicay Dolutegravir Sodium | 118 | 118 | 13 | $307K |
| Isentress Raltegravir Potassium | 112 | 112 | 12 | $218K |
| Rosuvastatin Calcium Generic | 110 | 254 | 27 | $1,202 |
| Dovato Dolutegravir Sodium/Lamivudine | 109 | 123 | 14 | $359K |
| Juluca Dolutegravir/Rilpivirine | 103 | 103 | Under 11 | $352K |
| Ozempic Semaglutide | 102 | 134 | 16 | $116K |
| Omeprazole Generic | 100 | 184 | 18 | $1,211 |
| Eliquis Apixaban | 95 | 192 | 23 | $110K |
| Zolpidem Tartrate Generic | 91 | 155 | 25 | $1,040 |
| Losartan Potassium Generic | 90 | 194 | 20 | $804 |
| Alprazolam Generic | 88 | 96 | 17 | $540 |
| Simvastatin Generic | 82 | 168 | 16 | $681 |
Brand drugs: 1,587 claims; generic drugs: 4,009 claims; opioid claims: 90.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald Pierone Jr. $1,174 ($1,174 in general payments such as food, travel and fees) from 15 companies. The largest payer was Revance Therapeutics, Inc. with $229.
| Company | Payments | Amount |
|---|---|---|
| Revance Therapeutics, Inc. | 6 | $229 |
| Novo Nordisk Inc NVO | 4 | $184 |
| ViiV Healthcare Company GSK | 6 | $181 |
| CVRx, Inc. CVRX | 1 | $154 |
| Abbott Laboratories ABT | 2 | $112 |
| Edwards Lifesciences Corporation EW | 1 | $69.47 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $55.31 |
| Abbvie Inc. ABBV | 2 | $44.68 |
| Solta Medical, a division of Bausch Health US, LLC | 2 | $32.9 |
| Esperion Therapeutics, Inc. ESPR | 1 | $23.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.